Answers are grounded in this paper and cite their sources.
SSRIs and SNRIs have been recognized as the primary therapeutic interventions for anxiety disorders. Although numerous SSRIs and SNRIs are available and often considered equally effective, objective differences in their anxiolytic effects and underlying mechanisms remain unclear. In this study, four major SSRIs and SNRIs—sertraline (SER), escitalopram (ESC), duloxetine (DUL), and venlafaxine (VEN)—were selected and their anxiolytic‐like effects were evaluated in zebrafish using the novel tank test. The biological mechanism underlying the anxiolytic‐like effects was also examined. The present study was predicated on the evaluation of monoamine receptor and transporter gene expression levels. The results demonstrated that SER showed a trend toward increased exploratory behavior and significantly decreased freezing duration, exhibiting the most stable anxiolytic‐like profile, followed by ESC. The administration of DUL was primarily associated with a trend toward increased erratic movements rather than clear anxiolysis. Meanwhile, VEN did not demonstrate a substantial difference from the control group. These distinct behavioral profiles may be attributable not only to increased serotonin activity but also to distinct dopamine activity and associated transcriptional alterations. Further studies are needed to elucidate the biological mechanisms of the anxiolytic effects of each antidepressant.
No takes yet. Share an insight, caveat, or question.
Shinokawa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: